Mark-Jan Ploegstra1, Willemijn M H Zijlstra2, Johannes M Douwes2, Hans L Hillege3, Rolf M F Berger2. 1. Centre for Congenital Heart Diseases, Department of Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, The Netherlands. Electronic address: m.ploegstra@umcg.nl. 2. Centre for Congenital Heart Diseases, Department of Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, The Netherlands. 3. Department of Epidemiology, University Medical Centre Groningen, University of Groningen, The Netherlands.
Abstract
BACKGROUND: Despite the introduction of targeted therapies in pediatric pulmonary arterial hypertension (PAH), prognosis remains poor. For the definition of treatment strategies and guidelines, there is a high need for an evidence-based recapitulation of prognostic factors. The aim of this study was to identify and evaluate prognostic factors in pediatric PAH by a systematic review of the literature and to summarize the prognostic value of currently reported prognostic factors using meta-analysis. METHODS AND RESULTS: Medline, EMBASE and Cochrane Library were searched on April 1st 2014 to identify original studies that described predictors of mortality or lung-transplantation exclusively in children with PAH. 1053 citations were identified, of which 25 were included for further analysis. Hazard ratios (HR) and 95% confidence intervals were extracted from the papers. For variables studied in at least three non-overlapping cohorts, a combined HR was calculated using random-effects meta-analysis. WHO functional class (WHO-FC, HR 2.7), (N-terminal pro-) brain natriuretic peptide ([NT-pro]BNP, HR 3.2), mean right atrial pressure (mRAP, HR 1.1), cardiac index (HR 0.7), indexed pulmonary vascular resistance (PVRi, HR 1.3) and acute vasodilator response (HR 0.3) were identified as significant prognostic factors (p ≤ 0.001). CONCLUSIONS: This systematic review combined with separate meta-analyses shows that WHO-FC, (NT-pro)BNP, mRAP, PVRi, cardiac index and acute vasodilator response are consistently reported prognostic factors for outcome in pediatric PAH. These variables are useful clinical tools to assess prognosis and should be incorporated in treatment strategies and guidelines for children with PAH.
BACKGROUND: Despite the introduction of targeted therapies in pediatric pulmonary arterial hypertension (PAH), prognosis remains poor. For the definition of treatment strategies and guidelines, there is a high need for an evidence-based recapitulation of prognostic factors. The aim of this study was to identify and evaluate prognostic factors in pediatric PAH by a systematic review of the literature and to summarize the prognostic value of currently reported prognostic factors using meta-analysis. METHODS AND RESULTS: Medline, EMBASE and Cochrane Library were searched on April 1st 2014 to identify original studies that described predictors of mortality or lung-transplantation exclusively in children with PAH. 1053 citations were identified, of which 25 were included for further analysis. Hazard ratios (HR) and 95% confidence intervals were extracted from the papers. For variables studied in at least three non-overlapping cohorts, a combined HR was calculated using random-effects meta-analysis. WHO functional class (WHO-FC, HR 2.7), (N-terminal pro-) brain natriuretic peptide ([NT-pro]BNP, HR 3.2), mean right atrial pressure (mRAP, HR 1.1), cardiac index (HR 0.7), indexed pulmonary vascular resistance (PVRi, HR 1.3) and acute vasodilator response (HR 0.3) were identified as significant prognostic factors (p ≤ 0.001). CONCLUSIONS: This systematic review combined with separate meta-analyses shows that WHO-FC, (NT-pro)BNP, mRAP, PVRi, cardiac index and acute vasodilator response are consistently reported prognostic factors for outcome in pediatric PAH. These variables are useful clinical tools to assess prognosis and should be incorporated in treatment strategies and guidelines for children with PAH.
Authors: Diederik E van der Feen; Guido P L Bossers; Quint A J Hagdorn; Jan-Renier Moonen; Kondababu Kurakula; Robert Szulcek; James Chappell; Francesco Vallania; Michele Donato; Klaas Kok; Jaskaren S Kohli; Arjen H Petersen; Tom van Leusden; Marco Demaria; Marie-José T H Goumans; Rudolf A De Boer; Purvesh Khatri; Marlene Rabinovitch; Rolf M F Berger; Beatrijs Bartelds Journal: Sci Transl Med Date: 2020-07-29 Impact factor: 17.956
Authors: K T N Breeman; M Dufva; M J Ploegstra; V Kheyfets; T P Willems; J Wigger; K S Hunter; D D Ivy; R M F Berger; U Truong Journal: Int J Cardiol Date: 2019-05-10 Impact factor: 4.164
Authors: Benjamin S Frank; Michal Schäfer; Johannes M Douwes; D Dunbar Ivy; Steven H Abman; Jesse A Davidson; Sandra Burzlaff; Max B Mitchell; Gareth J Morgan; Lorna P Browne; Alex J Barker; Uyen Truong; Johannes C von Alvensleben Journal: Am J Physiol Heart Circ Physiol Date: 2019-12-20 Impact factor: 4.733
Authors: Emily Morell Balkin; Matt S Zinter; Satish K Rajagopal; Roberta L Keller; Jeffrey R Fineman; Martina A Steurer Journal: Pediatr Crit Care Med Date: 2018-08 Impact factor: 3.624
Authors: Michal Schäfer; Uyen Truong; Lorna P Browne; Gareth J Morgan; Michael Ross; Richard Ing; Kendall S Hunter; Vitaly O Kheyfets; Steven H Abman; D Dunbar Ivy; Neil Wilson Journal: Pediatr Cardiol Date: 2017-10-17 Impact factor: 1.655
Authors: Johannes Krämer; Felix Kreuzer; Michael Kaestner; Peter Bride; Fabian von Scheidt; Jannos Siaplaouras; Heiner Latus; Dietmar Schranz; Christian Apitz Journal: Pediatr Cardiol Date: 2018-03-14 Impact factor: 1.655
Authors: Catherine M Avitabile; Yan Wang; Xuemei Zhang; Heather Griffis; Sofia Saavedra; Samantha Adams; Lisa Herkert; David B Frank; Michael D Quartermain; Natalie E Rintoul; Holly L Hedrick; Laura Mercer-Rosa Journal: Ann Am Thorac Soc Date: 2020-11